MORC2 and breast cancer: Subsequently, 17-allylamino-17-demethoxy-geldanamycin (17-AAG), an N-terminal inhibitor of HSP90, by selecting many drugs for treating BC was found to effectively inhibit the growth and metastasis of MORC2-overexpressing BC.